Switch theme
Sign up to access all valuation multiples
NeuroOne Medical Technologies Corp operates as a medical technology company. It is focused on the development and commercialization of thin-film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, brain stimulation, and ablation solutions for patients suffering from brain-related disorders. The company business is in one operating segment, which is the business of development and commercialization of products related to comprehensive neuromodulation cEEG and sEEG recording, monitoring, ablation, and brain stimulation solutions.
2009
17
LTM Revenue $3.5M
LTM EBITDA n/a
$25.4M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
NeuroOne Medical has a last 12-month revenue of $3.5M and a last 12-month EBITDA of n/a.
In the most recent fiscal year, NeuroOne Medical achieved revenue of $3.5M and an EBITDA of -$11.8M.
NeuroOne Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
See NeuroOne Medical valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $2.0M | $3.5M | XXX | XXX | XXX |
| Gross Profit | -$0.1M | $0.5M | XXX | XXX | XXX |
| Gross Margin | -4% | 13% | XXX | XXX | XXX |
| EBITDA | -$11.8M | -$11.8M | XXX | XXX | XXX |
| EBITDA Margin | -602% | -343% | XXX | XXX | XXX |
| Net Profit | -$10.0M | -$11.9M | XXX | XXX | XXX |
| Net Margin | -512% | -343% | XXX | XXX | XXX |
| Net Debt | n/a | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, NeuroOne Medical's stock price is $1.
NeuroOne Medical has current market cap of $26.2M, and EV of $25.4M.
See NeuroOne Medical trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $25.4M | $26.2M | XXX | XXX | XXX | XXX | $-0.46 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, NeuroOne Medical has market cap of $26.2M and EV of $25.4M.
NeuroOne Medical's trades at 7.3x LTM EV/Revenue multiple, and n/a LTM EBITDA.
Analysts estimate NeuroOne Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for NeuroOne Medical and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $25.4M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | XXX | XXX |
| P/E | n/a | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpNeuroOne Medical's NTM/LTM revenue growth is -100%
NeuroOne Medical's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.8M for the same period.
Over next 12 months, NeuroOne Medical's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate NeuroOne Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for NeuroOne Medical and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 77% | XXX | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | XXX | XXX | XXX |
| EBITDA Growth | 1% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | n/a | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.8M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 147% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 376% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
NeuroOne Medical acquired XXX companies to date.
Last acquisition by NeuroOne Medical was XXXXXXXX, XXXXX XXXXX XXXXXX . NeuroOne Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was NeuroOne Medical founded? | NeuroOne Medical was founded in 2009. |
| Where is NeuroOne Medical headquartered? | NeuroOne Medical is headquartered in United States of America. |
| How many employees does NeuroOne Medical have? | As of today, NeuroOne Medical has 17 employees. |
| Who is the CEO of NeuroOne Medical? | NeuroOne Medical's CEO is Mr. David A. Rosa. |
| Is NeuroOne Medical publicy listed? | Yes, NeuroOne Medical is a public company listed on NAS. |
| What is the stock symbol of NeuroOne Medical? | NeuroOne Medical trades under NMTC ticker. |
| When did NeuroOne Medical go public? | NeuroOne Medical went public in 2012. |
| Who are competitors of NeuroOne Medical? | Similar companies to NeuroOne Medical include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of NeuroOne Medical? | NeuroOne Medical's current market cap is $26.2M |
| What is the current revenue of NeuroOne Medical? | NeuroOne Medical's last 12-month revenue is $3.5M. |
| What is the current EV/Revenue multiple of NeuroOne Medical? | Current revenue multiple of NeuroOne Medical is 7.3x. |
| What is the current revenue growth of NeuroOne Medical? | NeuroOne Medical revenue growth between 2023 and 2024 was 77%. |
| Is NeuroOne Medical profitable? | Yes, NeuroOne Medical is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
